News

Press Releases

Select Year:
May 8, 2025 08:00 am

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

April 29, 2025 08:30 am

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

April 16, 2025 07:00 am

Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

April 14, 2025 08:30 am

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

April 11, 2025 08:30 am

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement

April 9, 2025 08:30 am

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

March 20, 2025 08:30 am

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice ("GMP") Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

March 13, 2025 08:30 am

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

March 3, 2025 07:30 am

Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

February 25, 2025 07:30 am

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

1 2